BIOM-01. TYROSINE KINASE INHIBITORS AS A TREATMENT OF SYMPTOMATIC CNS METASTASES IN ONCOGENE-DRIVEN NSCLC

BACKGROUND: Central nervous system (CNS) metastases occur frequently in oncogene-driven non-small cell lung cancer (NSCLC). Standard treatment (i.e surgery, whole brain radiation therapy or stereotactic radiosurgery) approaches can potentially delay systemic treatment and/or result in neurocognitive...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Benouaich-Amiel, Alexandra, Gal, Omer, Dudnik, Elizabeth, Rotem, Ofer, Finket, Inbar, Peretz, Idit, Zer, Alona, Mandel, Jacob, Siegal, Tali, Bar, Jair, Yust-Katz, Shlomit
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Biomarkers
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7650376/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.001
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars